rhosis, the morphological abnormalities in the retinal glial cells are described as hepatic retinopathy. It causes impairments in neuron-glial communication. Based on the hypothesis, retinal gliopathy could be used as a marker of HE. CFF significantly decreased in parallel with the HE severity (7) .
The CFF test is performed by placing a portable device on the eyes. During the test, subjects are administered light pulses with decreasing frequency (from ≤60 Hz to 25 Hz) and are requested to press a switch as soon as the feeling of a fused light changes to a flickering light (7, 8) .
This study aimed to examine the prevalence of MHE in cirrhotic patients and compare the performance of the PHES and CFF tests for the diagnosing MHE. To date, no studies have assessed the usefulness of CFF as diagnostic tool for MHE in Turkish cirrhotic patients.
MATERIALS AND METHODS
This prospective study was conducted in the Gastroenterology Department, Kayseri Training and Research Hospital between Aug 2015 and May 2016. This study has been approved by the Ethics Committee of Erciyes University School of Medicine, and all subjects provided signed written consent forms.
Cirrhotic Patient Group
A total of 85 patients with cirrhosis without OHE were included. The diagnosis of cirrhosis was establishedon the basis of clinical, laboratory, endoscopic, or histopathological findings. The cirrhosis staging was determined according to the ChildTurcotte-Pugh (CTP) class (9) . The exclusion criteria were as follows: 1) presence or a history of OHE, 2) gastrointestinal bleeding within 4 weeks), 3) alcohol intake, 4)presence of an infection, 5) use of a psychoactive or antimicrobial medicine, 6) trans hepatic porto systemic shunt (TIPS) or shunt surgery, 7) hepatocellular carcinoma or other malignancies, 8) poorly controlled diabetes mellitus, 9) severe systemic disease (heart and renal failure), 11) neurodegenerative disorders, and 12) oculo-visual dysfunction. The demographic, clinical, and laboratory parameters of the cirrhotic group are presented in Table 1 .
Clinical evaluation of OHE was performed with neurological examination according to West-Haven criteria (WHC) and the clinical HE staging scale (5, 10) . All patients underwent the MiniMental State Examination, and in cases where the score was >25 (11), both the PHES and CFF tests were performed during the same session. The tests were performed in a soundless room with appropriate light by the clinical doctor (OM, BDO).
Control Group I (PHES)
We recruited 205 healthy subjects from the general population for generating a normative data for the PHES test. Exclusion criteria were as follows: 1) history of hepatic disease, 2) neuropsychiatric diseases, 3) diabetes mellitus, 4) severe systemic diseases (heart and renal failure), 5) consumption of alcohol or psychotropic drugs, and 6) inability to read. The subjects' age, sex, and education level were recorded. Healthy subjects were divided into four categories according to their age, with equal numbers of males and females (20-29, 30-39, 40-49, and ≥50 years), and each age group was also stratified into three subgroups according to their education levels (≤5, 5-12, and ≥12 education years). The numbers of male and female in each age and education groups were equal.
Control Group II (CFF)
We recruited 100 healthy subjects to evaluate the effects of age and education level on the CFF test results. The exclusion criteria were similar to those listed above for the control group I. The subjects' age, sex, and education levels were recorded. This control group was used to determine the influence of age and education level on CFF performance.
Psychometric Tests
In this study, we used a battery of psychometric tests, comprising the number connection test (NCTA and B), digit symbol test (DST), serial dotting test (SDT), and line drawing test (LDT). In these tests, the results were measured as NCT-A, NCT-B, SDT, LDT in seconds and DST in points. Tests were considered abnormal when test score was more than mean±2 standart deviations (SD) in comparison with that of the age-and education-matched controls (12, 13) . In addition, the patients who had ≥2 abnormal psychometric test results were accepted as MHE (6, 14 
CFF
The CFF test wasperformed using the HEPAtonorm.analyzer (R&R Medi-Business Freiburg GmbH, Freiburg Germany). After the subjects were well-informed regarding the procedure, the CFF test were measured eight times, and the mean score was determined. The whole analysis was completed in 10-15 min. CFF was considered abnormal at <39 Hz (6) .
Laboratory Measurements
On the same day as psychometric analysis, blood samples were collected for hematological (whole blood count, prothrombin time, and international normalized ratio INR) and biochemical tests. The laboratory test parameters were measured using standard methodologies. Venous ammonia levels were determine dusing the Blood Ammonia Checker II system (Daiichi Kagaku, Kyoto, Japan).
Statistical Analysis
Normality of data was assessed using the Shapiro-Wilk test. Parametric data were presented as mean±standard deviation (SD). The comparisons between the groups were performed using Student's t-test and Mann-Whitney U test. Categorical data were shown as percentages, and the chi-square (χ2) test was used to define the differences between the groups. Correlation analysis was performed using either Pearson's or Spearman's correlation analyses, depending on data distribution. The diagnostic accuracy, specificity, and sensitivity of the CFF test were assessed by the area under the receiver operating characteristic curves. Statistical analyses were performed using Statistical Package for the Social Sciences 15.0 (SPSS Inc.; Chicago, IL, USA), and p<0.05 was considered to be statistically significant.
RESULTS

Control Group I (PHES)
All subjects successfully completed all five tests. The mean age and education level of the control group was 46±10.3 and 8.6±3.03 years, respectively, and 105 subjects were men (51.2%). The mean age did not significantly differ between the male and female subjects. The results of NCT-A, NCT-B, LTT, SDT, and DST were 41.9±18.7, 87.3±27.3, 59.1±14.2, 83.1±11, and 30.7±13.2, respectively. The results of NCT-A, NCT-B, and LDT were inversely correlated with the education levels, whereas those of DST and SDT were positively correlated with the education levels. The results of NCT-A, NCT-B, and LDT were positively correlated with age, whereas those of DST and SDT were inversely correlated with age. Sex was not correlated with the PHES test results. The results of DST and LDT in subjects who were age and had a higher education were better. The mean PHES in the control group was 0.33±2.18 (median, 0; range,−8 to +5) points.
Control Group II (CFF)
All subjects successfully completed the CFF tests. In this study, 29 (41.4%) patients with cirrhosis had an abnormal CFF score (<39Hz), whereas 25 (35.7%) patients with cirrhosis had an abnormal PHES. Eleven of 29 patients with an abnormal CFF had a normal PHES, whereas seven of 25 patients with an abnormal PHES had an abnormal CFF score. Table 2 shows that the associations between PHES and CFF. Using PHES as the reference standard, at the cut-off of <39 Hz, CFF had a sensitivity of 39%, specificity of 82%, and diagnostic accuracy of 70.6% for diagnosing MHE. Furthermore, at the cut-off of <38 Hz, CFF had a sensitivity of 21.4%, specificity of 83%, and diagnostic accuracy of 0.72. The diagnostic performances of the different cut-off of CFF for predicting MHE are shown in Table 3 .
Critical flicker frequency was correlated with NCT-A (r=−0.451; p<0.01), NCT-B (r=−0.366; p<0.01), LDT (r=−0.41; p<0.002), DST (r=0.31; p<0.01), and SDT (r=−0.34; p<0.01). There was a good correlation between CFF and PHES (r=0.44; p=0.01). The results of the correlations analysis are shown in Table 4 .
Comparison of MHE and non-MHE
There was no difference in age, sex, and education level between patients with MHE and those without MHE (p>0.05). Serum AST and albumin levels were significantly lower in patients with MHE than in those without MHE. CFF was not correlated with age (r=−0.18; p=0.35), sex (r=−0.65; p=0.64), educational level (r=0.23; p=0.9), whereas CFF was moderately correlated with the CTP class (r=−0.31; p=0.02). The demographic and laboratory findings of patients with cirrhosis having and those not having MHE are shown in Table 5 .
DISCUSSION
The present study confirmed that 1) the prevalence of MHE increased among patients with cirrhosis and that of MHE determined on the basis of PHES and CFF was 35.7% and 41.4%, respectively, and 2) there was a significant correlation between CFF and PHES test results.
The CFF test is a neurophysiological method that evaluates the abilities of the cerebral cortex to identify flickering light (6,7). Sharma et al. (14) and Romero-Gomez et al. (15) The CFF values significantly decreased in parallel with the HE severity and were strongly correlated with all the PHES test, particularly NCT-A and B. When using the cut-off of <39 Hz, patients with MHE were distinguished from HE 0, with a sensitivity of 55% and a specificity of 100% (16) . In some studies, an abnormal CFF threshold was set at <38 Hz. Romero-Gomez et al. (15) reported that at this cut-off, CFF had a specificity of 77.2% and a sensitivity of 72.4% for predicting MHE and when using the cutoff of 39 Hz, they observed a lower specificity (61.4%) but a slightly better sensitivity (76.2%). They also reported that CFF of <38 Hz correlated better with a risk for developing OHE than CFF of 39 Hz. In another study, Keircheis et al. (16) also compared the diagnostic value of conventional PHES+CFF using a cut-off of <38 Hz and conventional PHES+CFF using a cut-off of <39 Hz to detect MHE in patients with cirrhosis. In this study, CFF (<39 Hz)+PHES had a greater sensitivity than CFF (<38 Hz)+PHES. While CFF (<38 Hz)+PHES had a sensitivity of 37.8% and a specificity of 89.5%, CFF (<39 Hz)+PHES had a sensitivity of 48.6% and a specificity of 89.5%. Authors have been concluded that PHES+CFF of <38 Hz to diagnose MHE have no advantage based on the specificity but showed a disadvantage regarding sensitivity to detect MHE (16) . In the present study, we found that CFF (<39 Hz) had 39% sensitivity and 82% specificity for diagnosing MHE using the PHES test as the standard of diagnosis and a diagnostic accuracy of 0.70, whereas CFF (<38 Hz) had a 21.4% sensitivity, 83% specificity, and diagnostic accuracy of 0.72.We also showed that CFF of <39Hz has a better sensitivity and specificity than CFF of <38 Hz). The CFF test has some advantages compared with the PHES test. For example, the PHES test is independent of age, education level, and socioeconomic background (8) . Contradicting previous reports, Dhimanet al. (17) reported that CFF was correlated with age in healthy subjects and patients with cirrhosis (r=−0.279 and r=−0.479, respectively), leading the authors to propose that age-matched CFF values should be used for diagnosing MHE. Keircheis et al. (16) also recently reported that there was a significant correlation between CFF and age in both healthy subjects and patients with cirrhosis. In addition, they showed that diagnostic accuracy and sensitivity reduced when age-matched cut-off values were used and concluded that age has no additional predictive value. In present study, we found that CFF was weakly correlated with age (r=0.303; p=0.001) in pa-tients with cirrhosis while CFF was not correlated with age in healthy subjects. Thus, we did not apply agematched CFF values in healthy subjects.
The prevalence of MHE reportedly varies between 30% and 84% among patients with liver cirrhosis (15, 16) . These differences in the prevalence of MHE may be because of the variations in the methods used for diagnosing MHE (PHES, CFF, inhibitory control test, electroencephalography, SP300 auditory, or their combinations) and the differences between the patient populations studied. Sharma et al. (18) reported that the prevalence of MHE among 110 patients with cirrhosis (CTP-A/B/C: 39/42/29) was detected to be 65.4% using the CFF test and 68% using the PHES test. Among patients with cirrhosis having MHE in this study, 44% were in CTP-A, 50% were CTP-B, and 76% in CTP-C. Romero-Gomez et al. (15) This study the some limitations. First, the results of LDT were interpreted with different scoring systems in the literature.
While the results of LDT in PHES Italian were interpreted using an error-weight time [w-LDT=LDTt×(1+LDTe/100)], PHES Germany and PHES Indian were interpreted using two separate parameters (LDT Time and LDT Error ). In our study, the LDT sum (complete time+error) scoring system was used, similar to that in Spain and Mexico studies. In the Korean study, authors compared calculated PHES scores using three different LDT scoring systems (LDTsum, w-LDT, and LDT time andLDT error ) in their own patients with cirrhosis. They reported that the prevalence of MHE in PHES Korean , PHES Italian , and PHES Spanish were 25.6%, 26.9%, and 27.5%, respectively (23). Second, blood ammonium levels were an important etiological factor in the pathogenesis of MHE. Sharma et al. (14) and Keircheiset al. (6) have also reported that there was a significant correlation between blood ammonium levels and CFF values. But in our study, blood ammonium levels could not be evaluated because of inadequate technical equipment. In addition, CFF test cannot be performed for patients with ophthalmological disorders and red-green blindness. This patient group should be evaluated with other methods.
We found that CFF is a reliable tool for diagnosing MHE. Critical flicker frequency test has several advantages such as easy administration, application by a non-specialist personal, and results that are independent of numeracy, literacy, and age. Critical flicker frequency test should be used as an adjunct to conventional PHES tests because of its low sensitivity for predicting MHE.
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